|
| ☉OHA: |
Sulfonylurea :(Amaryl...) : (kill Liver)
Thiazolidinedione(TZD) :(Actos, Avandia) : kill Liver
A-Glucosidase inhibitor :Acarbose(Glucobay) : kill Liver
Biguanide :Metformin(Glucophage): lactic acidosis/monitor
Kidney(「沒蜂蜜」所以太酸)
|
| ☉Insulin resistance syndrome |
→characterized by hyperinsulinemia and an increased prevalence of obesity,
hypertension, dyslipemia and type 2 diabetes mellitus.
→decreased HDL cholesterol levels (a significant risk factor for heart
disease), increased serum VLDL cholesterol and TG levels and, sometimes, a
★decreased LDL cholesterol level. |
| ☉Thyroid ca |
Thyroid medullary ca: MEN II: RET mutation: Calcitonin ↑↑
papillaruy ca: Thyroglobulin ↑↑ for f/u |
| ☉MEN |
MEN-I : parathyroid glands, pancreatic islet cells(Insulinoma)(gastrinoma:ZE), and pituitary gland.(3P)
MEN-IIA : medullary carcinoma of the thyroid, pheochromocytoma, and
hyperparathyroidism.
MEN-IIB : multiple mucosal neuromas, medullary carcinoma of the thyroid,
and pheochromocytoma(doctor of MED, Phil) |
| ☉glucose intolerance |
IGT(impaired glucose test): OGTT(2hr): 140-200 mg/dl
IFG(impaired fasting glucose): FPG(fasting plasma glucose): 110-126 mg/ml |
| ☉Insulinoma |
→Preoperative portal venous sampling
→Approximately 10% of insulinomas are malignant (metastases are present),
and 10% are multiple, particularly in patients with multiple endocrine
neoplasia type 1 (MEN 1).
→Adrenergic symptoms (hypoglycemia causes adrenalin release) include
weakness, sweating, tachycardia, palpitations, and hunger.
→Serum insulin levels of 10 mU/mL or more (normal <6 mU/mL)
Glucose levels of less than 40 mg/dL
C-peptide levels exceeding 2.5 ng/mL (normal <2 ng/mL)
|
| ☉Conn's syndrome |
→primary hyperaldosteronism.
→curable cause of hypertension |
| ☉Leptin |
(from the Greek leptos, meaning thin)
→a protein hormone with important effects in regulating body weight,
metabolism and reproductive function.
→approximately ~16 kDa in mass and encoded by the obese (ob) gene
→Genetically obese mice with inactivating mutations in the ob gene or the
gene encoding the leptin receptor (db gene)
→weight loss resulting from administration of leptin appears to result
from a combination of at least two fundamental effects:
1.Decreased hunger and food consumption, mediated at least in part by
inhibition of neuropeptide Y synthesis.(very potent stimulator of feeding
behavior)
2.Increased energy expenditure, measured as increased oxygen consumption,
higher body temperature and loss of adipose tissue mass.
→the ability of leptin to enhance secretion of gonadotropin-releasing
hormone, and thus luteinizing and follicle-stimulating hormones from the
anterior pituitary.
→The amount of leptin↓ expressed by adipocytes correlates well with the
lipid content↑ of the cells.
→Blood concentrations of leptin are usually increased in obese humans,
suggesting that they are in some way insensitive to leptin, rather than
suffering from leptin deficiency.
|
| ☉Rheumatic factor: |
Fc of IgG (GG變濕了) |
| ☉hereditary angiooedema: |
C1 esterase inhibitor(A-1都是第一名) |
| ☉Arthritis D/D: |
1.OA: weight bearing/ used joints, DIP, PIP, 1st CMC, but MCP rare
use-related pain, morning stiffness, crepitation
bony swelling of joints, eg. Heberden's node(DIP), Bouchard's
node(PIP)(很深的Hebride懸崖)
CXR: osteophytes
2.RA: PIP, MCP
pain, tenderness, swelling, morning stiffness, swan neck(intrinsic m.
atrophy), deviate to ulnar side
CXR: osteopenia, marginal erosions
★KCS, episcleritis,marginal ulcer of cornea, BOOP, Caplan's
syndrome(pneumoconiosis)
→→Tumor necrosis factor (TNF) inhibitors, Soluble Interleukin–1 (IL–1)
Receptor Therapy
3.AS: SI, hip
HLA B-27
CXR: bamboo spine(calcification of annulus fibrosis & ant. long. lig.)
→→Enthesopathy :involving an attachment of a tendon or ligament to bone
(enthesis). Inflammatory abnormalities of entheses are prominent findings
in seronegative spondyloarthopathies (ankylosing spondylitis, Reiters
syndrome, psoriatic arthritis) and may also be present to a lesser extent
in rheumatoid arthritis.
4.Gout: podagra(attack in the great toe): 90%
pain, fever
tophi, MSU
urate nephrosis, UA nephropathy/ nephrolithiasis
definite Dx: aspiration
|
| ☉Septic arthritis: |
WBC > 50000/mm3←→2000-20000/mm3 in RA |
| ☉JRA |
→systemic onset JRA:
a high intermittent fever and one of the following: lymphadenopathy,
hepatomegaly, splenomegaly, pericarditis, or a ★transient maculopapular
rash.
→Polyarticular onset JRA:
affecting 5 or more joints during the first 6 months of disease. About 25%
of these children are seropositive and these are not at excess risk for
developing uveitis.
→Pauciarticular onset JRA:
affects 4 or fewer joints, and this type being most prevalent, occurs in
about 60% of patients. Some of these patients might progress to
polyarticular involvement .
|
| ☉PM/DM |
→proximal m. weakness, dyspnea, interstitial lung dz., Raynaud's
phenomenon
→Helicotrope rash on eyelids...: lilac-colored, Gottron rash
→perivascular inflammation, perifascicular atrophy
→CK elevation |
| ☉Sjoegren's syndrome |
(飢渴的休葛蘭)
→destruction of exocrine glands(parotid gland...), eye/mouth dryness
→Criteria: Keratoconjunctivitis sicce(KCS), Xerostomia, Serologic autoAb,
Labial salivary gland biopsy
→ANA, RF, anti-La(SS-B) > anti-Ro(SS-A)
|
| ☉MCTD |
→anti-nuclear rebonucleoprotein(RNP)
→SLE/SSc/polymyositis/RA |
| ☉Systemic Sclerosis |
→CREST:★ anti-centromere
|
| ☉antimitochondrial antibody |
→positive in up to 94% of people with biliary cirrhosis, and 25% of those
with chronic active hepatic or iodophathic (of unknown cause) cirrhosis.
→helpful in distinguishing biliary (bile system) cirrhosis from liver
problems due to obstruction outside of the liver, viral hepatitis, and
alcoholic cirrhosis. |
| |
|
| |
|
|